V

Verona Pharma plc

D
VRNA
USD
-0.2
(-0.5214%)
Market Closed
21,227.00
حجم التداول
-1.60592
الربح لكل سهم
-
العائد الربحي
-23.850000
P/E
3,099,933,552.96
حجم السوق
اليوم
1.5164%
1 اسبوع
12.434%
1 شهر
19.027%
6 اشهر
158.012%
12 اشهر
160.478%
بداية السنة
92.145%
كل الوقت
0%

Title:
Verona Pharma plc

Sector:
Healthcare
Industry:
Biotechnology
Verona Pharma PLC is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for the treatment of respiratory diseases with unmet medical needs. The company is currently focusing on developing its Ensifentrine product candidate, which will treat chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF), and other respiratory diseases, including asthma.
هل تحتاج مساعدة او لديك استفسار؟